CRISPR-Cas9 Screening Identifies Therapeutic Targets for AML1-ETO Positive Leukemia

被引：0
|
作者：
Guo, Chengcai [1 ]
Liu, Yu [1 ]
Rao, Qing [1 ]
Qiu, Shaowei [2 ]
Gu, Runxia [2 ]
Wang, Min [2 ]
Wang, Jianxiang [1 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Expt Hematol, Natl Clin Res Ctr Blood Dis, Inst Hematol & Blood Dis Hosp, Tianjin, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Natl Clin Res Ctr Blood Dis, State Key Lab Expt Hematol, Haihe Lab Cell Ecosyst,Inst Hematol & Blood Dis H, Tianjin, Peoples R China
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-179262
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] CRISPR-Cas9 knockout screening for functional genomics
    Shen ZhongFu
    Ou GuangShuo
    SCIENCE CHINA-LIFE SCIENCES, 2014, 57 (07) : 733 - 734
  • [32] CRISPR-Cas9 knockout screening for functional genomics
    SHEN ZhongFu
    OU GuangShuo
    Science China(Life Sciences), 2014, (07) : 733 - 734
  • [33] CRISPR-Cas9 knockout screening for functional genomics
    ZhongFu Shen
    GuangShuo Ou
    Science China Life Sciences, 2014, 57 : 733 - 734
  • [34] The coexpression of AML1-ETO9a isoform and AML1-ETO in acute myeloid leukemia M2 subtype and its clinical significance
    Zhang, Hong
    Chen, Zi-xing
    He, Jun
    Miao, Yu-qin
    Cen, Jian-nong
    Qiu, Qiao-chen
    BLOOD, 2007, 110 (11) : 706A - 706A
  • [35] CRISPR-Cas9 Library Screening Identifies Novel Molecular Vulnerabilities in KMT2A-Rearranged Acute Lymphoblastic Leukemia
    Schneider, Pauline
    Wander, Priscilla
    Arentsen-Peters, Susan T. C. J. M.
    Vrenken, Kirsten S.
    Rockx-Brouwer, Dedeke
    Adriaanse, Fabienne R. S.
    Hoeve, Veerle
    Paassen, Irene
    Drost, Jarno
    Pieters, Rob
    Stam, Ronald W.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (17)
  • [36] AML1-ETO9a, an alternatively spliced form of AML1-ETO, collaborates with AMLI-ETO to promote leukemogenesis.
    Yan, M
    Wang, Y
    Peterson, LF
    Kanbe, E
    Boyapati, A
    Zhang, DE
    BLOOD, 2005, 106 (11) : 195A - 196A
  • [37] Targeted disruption of the interaction between AML1-ETO and the nuclear receptor co-repressor induces apoptosis of AML1-ETO leukemia cells.
    Saunthararajah, Y
    Wang, JX
    Futaki, M
    Igarashi, T
    Redner, RL
    Liu, JM
    BLOOD, 2000, 96 (11) : 458A - 459A
  • [38] CRISPR-Cas9 screening reveals novel targets that govern HNSCC response to radiation therapy
    Kelley, Vanessa M.
    Baro, Marta
    Katoch, Aanchal
    Phoomak, Chatchai
    Lee, Hojin
    Contessa, Joseph
    CANCER RESEARCH, 2022, 82 (12)
  • [39] Proteomics of AML1/ETO target proteins: AML1-ETO targets a C/EBP-NM23 pathway
    Singh S.M.
    Trivedi A.K.
    Lochab S.
    Christopeit M.
    Hiddemann W.
    Behre G.
    Clinical Proteomics, 2010, 6 (3) : 83 - 91
  • [40] A CRISPR-Cas9 screen identifies EXO1 as a formaldehyde resistance gene
    Gao, Yuandi
    Guitton-Sert, Laure
    Dessapt, Julien
    Coulombe, Yan
    Rodrigue, Amelie
    Milano, Larissa
    Blondeau, Andreanne
    Larsen, Nicolai Balle
    Duxin, Julien P.
    Hussein, Samer
    Fradet-Turcotte, Amelie
    Masson, Jean-Yves
    NATURE COMMUNICATIONS, 2023, 14 (01)
12345